Guanidine Hydrazone (2a): A Novel Disease-Modifying Treatment for Parkinson's Disease

被引：0
|
作者：
Persico, Michele [1 ]
Fang, Tracy Shi Zhang [1 ]
Eleuteri, Simona Carmen [1 ]
Simon, David Keith [1 ]
机构：
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA
来源：
ANNALS OF NEUROLOGY | 2023年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S221
引用
收藏
页码：S174 / S174
页数：1
相关论文
共 50 条
  • [31] Disease-modifying treatment for Alzheimer's disease: the neurotrophic approach
    Bossi, L
    ALZHEIMERS REPORTS, 1998, 1 : S29 - S30
  • [32] Emerging prospects for the disease-modifying treatment of Alzheimer's disease
    Walker, LC
    Ibegbu, CC
    Todd, CW
    Robinson, HL
    Jucker, M
    LeVine, H
    Gandy, S
    BIOCHEMICAL PHARMACOLOGY, 2005, 69 (07) : 1001 - 1008
  • [33] lmmunomodulation - a disease-modifying avenue for treatment of Huntington's disease?
    Bjorkqvist, Maria
    JOURNAL OF NEUROCHEMISTRY, 2016, 137 (05) : 670 - 672
  • [34] MANF: a new potential disease-modifying drug candidate for Parkinson's disease
    Commissiong, J.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S109 - S109
  • [35] Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics
    Gerlach, Manfred
    Maetzler, Walter
    Broich, Karl
    Hampel, Harald
    Rems, Lucas
    Reum, Torsten
    Riederer, Peter
    Stoeffler, Albrecht
    Streffer, Johannes
    Berg, Daniela
    JOURNAL OF NEURAL TRANSMISSION, 2012, 119 (01) : 39 - 52
  • [36] Therapeutic innovation in Parkinson's disease: a 2020 update on disease-modifying approaches
    Colombo, Daniele
    Pnevmatikou, Paraskevi
    Melloni, Elsa
    Keywood, Charlotte
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2020, 20 (10) : 1047 - 1064
  • [37] Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeutics
    Manfred Gerlach
    Walter Maetzler
    Karl Broich
    Harald Hampel
    Lucas Rems
    Torsten Reum
    Peter Riederer
    Albrecht Stöffler
    Johannes Streffer
    Daniela Berg
    Journal of Neural Transmission, 2012, 119 : 39 - 52
  • [38] The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF Biomarkers
    Paoletti, Federico Paolini
    Gaetani, Lorenzo
    Parnetti, Lucilla
    BIOMOLECULES, 2020, 10 (02)
  • [39] Mitochondrial therapy for Parkinson's disease: Neuroprotective pharmaconutrition may be disease-modifying
    Kones, Richard
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2010, 2 : 185 - 198
  • [40] Targeting β-amyloid by the A2V Aβ variant: a novel disease-modifying strategy for the treatment of Alzheimer's disease
    Di Fede, G.
    Diomede, L.
    Catania, M.
    Maderna, E.
    Moda, F.
    Ruggerone, M.
    Romeo, M.
    Morbin, M.
    Palamara, L.
    Campagnani, I.
    Colombo, L.
    Rossi, A.
    Cagnotto, A.
    Messa, M.
    De Luigi, A.
    Mancini, S.
    Stravalaci, M.
    Gobbi, M.
    Borsello, T.
    Salmona, M.
    Tagliavini, F.
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 41 : S21 - S21
12345